The global market for biopsy devices was estimated to be worth USD 1,600 million in 2014 and is expected to reach USD 2,414 million by 2020, growing at a CAGR of 7.1% during the forecast period from 2014 to 2021. A biopsy is a medical test performed on a tissue or cell to examine, determine and remove the affected tissue from the body.
If a patient is suspected to have cancer, a biopsy is used to extract tissue samples for diagnosis and determination of cancer. The procedure is performed by interventional radiologists to detect cancer and the end-users of this market are hospitals, diagnostic centers, and other medical clinics.
Global Biopsy Devices Market- Market Dynamics
The biopsy devices market has great potential. The report details several driving and restraining factors for the global biopsy devices market. Some of them are listed below.
High incidence of cancer
Increasing public awareness about chronic diseases
Growing geriatric population
Increasing demand for minimally invasive procedures
Need for disease screenings for their early diagnosis and treatment
High price of technologically advanced devices
The market for biopsy devices is segmented based on the product type, which includes biopsy needles (disposable and reusable), biopsy guidance systems (manual and robotic), needle-based biopsy guns (vacuum assisted biopsy devices, core needle biopsy devices and fine needle aspiration devices), biopsy forceps (cold forceps and hot forceps), and others such as biopsy punches, brushes, and curettes.
Based on geography, the global market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America dominates the worldwide market for biopsy devices, followed by Europe, owing to research and development activities and innovative technologies. APAC is expected to develop at a greater pace due to increasing incidences of cancer, aging population, technological advancements and increasing per capita income.
Global Biopsy Devices Market- Competitive Landscape
Many players in this market are trying to expand their product portfolio in order to top the global and regional market. Top companies are expanding their growth in this market by acquiring other companies. A few companies have adopted product innovation and new product launches as their key business strategy to ensure their dominance in this market.
Some of the key players in the market are:
C R Bard
Devicor Medical Products
Intact Medical Corporation
Key Deliverables in the Study
Market analysis for the biopsy devices market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the biopsy devices market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)